Press Releases

GelStat Corporation Engages Newbridge Financial, Inc. as Its Strategic Advisor

Download PDF

PALM CITY, FL -- (Marketwired) -- 04/20/15 -- GelStat Corporation (OTC PINK: GSAC) (News), a fully integrated consumer healthcare company engaged in the development, marketing, branding and manufacturing of innovative over-the-counter (OTC) consumer healthcare products, announced today it has retained Newbridge Financial, Inc. as its strategic advisor.

"After evaluating numerous strategic advisory firms, we are excited to have engaged Newbridge Financial, Inc. Its principals are extremely knowledgeable of both the financial markets and the cannabis industry. We are confident that their experience and plethora of connections throughout the industry will accelerate the execution of our business plan and open up additional opportunities that weren't even on our radar. We have witnessed other companies they have advised make tremendous strides with their support," said Gerald Kieft, GelStat Corporation's CFO.

The agreement covers a wide range of services including, but not limited to:

  • Study and review the business, operations, financial performance and development initiatives to provide advice to the Company;
  • Assist the Company in attempting to formulate the optimal strategy to meet the Company's working capital and resource needs;
  • Identify, make introductions to and evaluate potential business contacts within the industry that may help the company advance its business opportunities, and in appropriate instances, negotiate on the company's behalf; 
  • Help assist the Company in structuring a placement agent agreement with broker/dealers or other sources of debt and/or equity financing;
  • Help assist the Company in formulating the terms and structure of any debt or equity financings contemplated by the Company;
  • Identify and introduce the Company to prospective private institutional financial investors, private lender and/or other sources of capital.

"We are very excited to assist in the development of GelStat's business model as we feel there are tremendous opportunities within their industry. It is our goal to help accelerate their successes and leverage their core strengths to give them added advantages and differentiated products within the marketplace," said Leonard Sokolow, CEO & President of Newbridge Financial, Inc.

Make sure you are first to receive timely information on GelStat Corporation when it hits the newswire. Sign up for GelStat's email news alert system today at: http://ir.stockpr.com/gelstat2/email-alerts

ABOUT NEWBRIDGE FINANCIAL

Newbridge Financial, Inc., as the holding company for Newbridge Securities Corporation provides strategic management consulting services to growth companies and explores the development of lines of business complementary to but outside of the financial services industry.

For more information on Newbridge, please visit www.newbridgesecurities.com. Contact: Thomas Casolaro, CEO Newbridge Securities, 561-395-1220; tcasolaro@newbridgesecurities.com.
Source: Newbridge Financial, Inc., 1451 W. Cypress Creek Rd., Fort Lauderdale, FL 33309; Tel: 877-447-9625.

ABOUT GELSTAT CORPORATION

GelStat Corporation is a publicly-traded company trading under the symbol ("GSAC") that is engaged in research, development, marketing and branding of innovative over-the-counter (OTC) consumer healthcare products addressing very large markets. Through its recent acquisition of Mastix Medica (now a wholly owned subsidiary of GelStat), it is now a fully integrated healthcare products company with proprietary manufacturing capabilities. For more information, visit www.gelstat.com.

Mastix Medica develops and manufactures niche healthcare products in dosage forms like tableted chewing gum, chewable tablets and lozenges. Mastix Medica is one of very few companies in the world that has the ability to make tableted chewing gum products at room temperature versus the traditional boiling process which can degrade the active ingredients and reduce their efficacy. Most importantly, Mastix Medica has a patent pending process for incorporating hemp oil into chewing gum, lozenges and chewable tablets. For more information on Mastix Medica visit: http://mastixmedica.com

CBD (Cannabidiol) is a natural constituent of hemp oil, which is a well-known dietary supplement and food ingredient. Naturally occurring CBD in hemp oil possesses no psychoactive qualities. Gelstat, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA).

FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE: These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.

Safe Harbor Statement

This press release contains forward-looking statements including the projected revenue that Mastix may produce, the forecasted size of the migraine market and the forecasted value of the energy drink market. Forward-looking statements can be identified by words such as "anticipates," "intends," "plans," "seeks," "believes," "estimates," "expects" and similar references to future periods.

Forward-looking statements are based on our current expectations and assumptions regarding our business, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. Our actual results may differ materially from those contemplated by the forward-looking statements. We caution you therefore against relying on any of these forward-looking statements. They are neither statements of historical fact nor guarantees or assurances of future performance. Important factors that could cause actual results to differ materially from those in the forward-looking statements include the ability of Mastix to obtain future customers, regulatory and other legal changes which may affect the forecasts, and the demand for hemp based products as well as the ability to sell hemp products.

Any forward-looking statement made by us in this press release speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law.

FOR ADDITIONAL INFORMATION CONTACT:

Gerald Kieft
CFO
GelStat Corporation
772-283-0020

Source: GelStat Corporation